The MarketWatch News Department was not involved in the creation of this content. SAN DIEGO, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. ("Biosplice"), a clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results